title: Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects.
abstract: BACKGROUND
  Retinitis pigmentosa is a heterogeneous group of inherited neurodegenerative retinal disorders characterized by a progressive peripheral vision loss and night vision difficulties, subsequently leading to central vision impairment. Chronic microglia activation is associated with various neurodegenerative diseases including retinitis pigmentosa. The objective of this study was to quantify microglia activation in the retina of P23H rats, an animal model of retinitis pigmentosa, and to evaluate the therapeutic effects of TUDCA (tauroursodeoxycholic acid), which has been described as a neuroprotective compound.
  
  
  METHODS
  For this study, homozygous P23H line 3 and Sprague-Dawley (SD) rats were injected weekly with TUDCA (500 mg/kg, ip) or vehicle (saline) from 20 days to 4 months old. Vertical retinal sections and whole-mount retinas were immunostained for specific markers of microglial cells (anti-CD11b, anti-Iba1 and anti-MHC-II). Microglial cell morphology was analyzed and the number of retinal microglial was quantified.
  
  
  RESULTS
  Microglial cells in the SD rat retinas were arranged in regular mosaics homogenously distributed within the plexiform and ganglion cell layers. In the P23H rat retina, microglial cells increased in number in all layers compared with control SD rat retinas, preserving the regular mosaic distribution. In addition, a large number of amoeboid CD11b-positive cells were observed in the P23H rat retina, even in the subretinal space. Retinas of TUDCA-treated P23H animals exhibited lower microglial cell number in all layers and absence of microglial cells in the subretinal space.
  
  
  CONCLUSIONS
  These results report novel TUDCA anti-inflammatory actions, with potential therapeutic implications for neurodegenerative diseases, including retinitis pigmentosa.
authors.forename: Agustina
authors.initials: A
authors.lastname: Noailles
authors.forename: Laura
authors.initials: L
authors.lastname: Fernández-Sánchez
authors.forename: Pedro
authors.initials: P
authors.lastname: Lax
authors.forename: Nicolás
authors.initials: N
authors.lastname: Cuenca
mesh_terms: D000818:Animals; D002452:Cell Count; D004195:Disease Models, Animal; D007150:Immunohistochemistry; D017628:Microglia / Q000187:drug effects*; D018613:Microscopy, Confocal; D018696:Neuroprotective Agents / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012162:Retinal Degeneration / Q000473:pathology*; D013655:Taurochenodeoxycholic Acid / Q000494:pharmacology*
chemical_list: D018696:Neuroprotective Agents; D013655:Taurochenodeoxycholic Acid; C031655:ursodoxicoltaurine